First-line camrelizumab plus chemotherapy followed by camrelizumab-apatinib maintenance for ES-SCLC: a single-arm phase II study
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.lungcan.2026.109623
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0169500226006847
其他信息:
出版社: Elsevier BV
作者: Minghui Zhang; Mingyuan Guo; Lijun Li; Changfan Qu; Jinglei Liu; Haihong Pu; Xin Li; Yinghong Li; Li Guo; Zhao Jin; Chen Yang; Yu Zhang; Jian Shen; Yue Gao; Qingwei Meng; Yanbin Zhao

